Real-world study provides new insights into safety of new Alzheimer's drug lecanemab
As new Alzheimer's drugs move from clinical trials into everyday care, families are asking whether these treatments are safe, how long patients can stay on them and whether they truly slow the disease outside tightly controlled studies.
<p>As new Alzheimer's drugs move from clinical trials into everyday care, families are asking whether these treatments are safe, how long patients can stay on them and whether they truly slow the disease outside tightly controlled studies.</p>